期刊文献+

药品说明缺陷的法律分析 被引量:2

A legal Analysis of Drug Instruction Defects
在线阅读 下载PDF
导出
摘要 根据产品责任法理论阐述了药品缺陷的含义以及我国对药品说明的有关规定;并根据药品的特殊性,深入分析了药品说明缺陷的判断因素,以及认定药品说明缺陷应注意的问题,有助于药品生产者、经营者、医师、药师等在产品和医疗服务中规范行事。提出在司法实践中,要确认生产者、销售者或医师是否存在说明缺陷,应对药品的说明对象、说明方式以及说明时间、说明的充分性以及对明显或众所周知的危险进行警告等方面进行综合考虑评估。 In accordance with the theories of products liability law, the author clarify the definition of drug defect and relevant stipulations on drug instruction in China. Taking the medical particularity into consideration, the author penetrates into the factors to judge the drug instruction defects and some matters for attention while cognising the drug instruction defects, in order to help drug manufacturers, drug operators, physicians and apothecaries to standardize their products and medical service. It is advocated that, in judicial practice, comprehensive appraisal shall be carried out in many aspects, e. g. who to instruct, how and when, sufficiency, warning the obvious and well known dangers, etc. in this way, to confirm the instruction defects by drug manufacturers, distributors of physicians.
作者 李宇阳
出处 《中国医院管理》 北大核心 2004年第2期60-62,共3页 Chinese Hospital Management
关键词 药品 说明缺陷 判断 drug, instruction defect, judge
  • 相关文献

参考文献2

  • 1[1]鲍一飞.对一宗乙肝命案的独家调查[N].都市快报,2002-05-08(7)
  • 2[2]朱怀祖.药物责任与消费者保护[M].台湾:台湾五南图书公司,1998

同被引文献6

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部